Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05562349
PHASE2

Clavulanic Acid for the Treatment of Cocaine Use Disorder

Sponsor: Temple University

View on ClinicalTrials.gov

Summary

A dose escalation study to assess the efficacy and safety of Clavulanic Acid (CLAV) vs. placebo (PBO) for the treatment of cocaine use disorder (CUD)

Official title: A Randomized, Double-Blind, Placebo-Controlled Phase 2a Pilot Study to Assess the Efficacy and Safety of Clavulanic Acid vs. Placebo for the Treatment of Cocaine Use Disorder

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

65

Start Date

2023-05-03

Completion Date

2024-07

Last Updated

2024-05-02

Healthy Volunteers

No

Interventions

DRUG

Clavulanic Acid Only Product

Drug will be given in 250mg capsules

DRUG

Placebo

Capsule with no active medication - identical to drug capsule

Locations (2)

University of Pennsylvania

Philadelphia, Pennsylvania, United States

MUSC

Charleston, South Carolina, United States